Skip to main content

EMEA (Europe, Middle East and Africa) Neurostimulation Devices Market 2017

Press Release   •   Jun 05, 2017 05:48 EDT

In this report, the EMEA Neurostimulation Devices Market 2017 is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Neurostimulation Devices for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Neurostimulation Devices market competition by top manufacturers/players, with Neurostimulation Devices sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Medtronic
Boston Scientific
St.Jude Medical
LivaNova (Cyberonics)
Nevro
Inspire Medical Systems
NeuroPace
Autonomic Technologies
NeuroSigma
Neuros Medical
ImThera Medical
Synapse Biomedical
Atrotech
ElectroCore
SPR Therapeutics
NeuroMetrix

Request more information at http://globalqyresearch.com/download-sample/219467 

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Neurostimulation Devices for each application, including
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis

If you have any special requirements, please let us know and we will offer you the report as you want.

View full report at http://globalqyresearch.com/emea-europe-middle-east-and-africa-neurostimulation-devices-market-report-2017

Table of Contents

EMEA (Europe, Middle East and Africa) Neurostimulation Devices Market Report 2017
1 Neurostimulation Devices Overview
1.1 Product Overview and Scope of Neurostimulation Devices
1.2 Classification of Neurostimulation Devices
1.2.1 EMEA Neurostimulation Devices Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Neurostimulation Devices Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Spinal Cord Stimulation (SCS)
1.2.4 Gastric Electric Stimulation (GES)
1.2.5 Deep Brain Stimulation (DBS)
1.2.6 Sacral Nerve Stimulation (SNS)
1.2.7 Vagus Nerve Stimulation (VNS)
1.3 EMEA Neurostimulation Devices Market by Application/End Users
1.3.1 EMEA Neurostimulation Devices Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Pain Management
1.3.3 Parkinson's Disease
1.3.4 Urinary and Fecal Incontinence
1.3.5 Epilepsy
1.3.6 Gastroparesis
1.4 EMEA Neurostimulation Devices Market by Region
1.4.1 EMEA Neurostimulation Devices Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Neurostimulation Devices (2012-2022)
1.5.1 EMEA Neurostimulation Devices Sales and Growth Rate (2012-2022)
1.5.2 EMEA Neurostimulation Devices Revenue and Growth Rate (2012-2022)

2 EMEA Neurostimulation Devices Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Neurostimulation Devices Market Competition by Players/Manufacturers
2.1.1 EMEA Neurostimulation Devices Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Neurostimulation Devices Revenue and Share by Players (2012-2017)
2.1.3 EMEA Neurostimulation Devices Sale Price by Players (2012-2017)
2.2 EMEA Neurostimulation Devices (Volume and Value) by Type/Product Category
2.2.1 EMEA Neurostimulation Devices Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Neurostimulation Devices Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Neurostimulation Devices Sale Price by Type (2012-2017)
2.3 EMEA Neurostimulation Devices (Volume) by Application
2.4 EMEA Neurostimulation Devices (Volume and Value) by Region
2.4.1 EMEA Neurostimulation Devices Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Neurostimulation Devices Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Neurostimulation Devices Sales Price by Region (2012-2017)

3 Europe Neurostimulation Devices (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Neurostimulation Devices Sales and Value (2012-2017)
3.1.1 Europe Neurostimulation Devices Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Neurostimulation Devices Revenue and Growth Rate (2012-2017)
3.2 Europe Neurostimulation Devices Sales and Market Share by Type
3.3 Europe Neurostimulation Devices Sales and Market Share by Application
3.4 Europe Neurostimulation Devices Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Neurostimulation Devices Sales Volume by Countries (2012-2017)
3.4.2 Europe Neurostimulation Devices Revenue by Countries (2012-2017)
3.4.3 Germany Neurostimulation Devices Sales and Growth Rate (2012-2017)
3.4.4 France Neurostimulation Devices Sales and Growth Rate (2012-2017)
3.4.5 UK Neurostimulation Devices Sales and Growth Rate (2012-2017)
3.4.6 Russia Neurostimulation Devices Sales and Growth Rate (2012-2017)
3.4.7 Italy Neurostimulation Devices Sales and Growth Rate (2012-2017)
3.4.8 Benelux Neurostimulation Devices Sales and Growth Rate (2012-2017)

4 Middle East Neurostimulation Devices (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Neurostimulation Devices Sales and Value (2012-2017)
4.1.1 Middle East Neurostimulation Devices Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Neurostimulation Devices Revenue and Growth Rate (2012-2017)
4.2 Middle East Neurostimulation Devices Sales and Market Share by Type
4.3 Middle East Neurostimulation Devices Sales and Market Share by Application
4.4 Middle East Neurostimulation Devices Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Neurostimulation Devices Sales Volume by Countries (2012-2017)
4.4.2 Middle East Neurostimulation Devices Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Neurostimulation Devices Sales and Growth Rate (2012-2017)
4.4.4 Israel Neurostimulation Devices Sales and Growth Rate (2012-2017)
4.4.5 UAE Neurostimulation Devices Sales and Growth Rate (2012-2017)
4.4.6 Iran Neurostimulation Devices Sales and Growth Rate (2012-2017)

5 Africa Neurostimulation Devices (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Neurostimulation Devices Sales and Value (2012-2017)
5.1.1 Africa Neurostimulation Devices Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Neurostimulation Devices Revenue and Growth Rate (2012-2017)
5.2 Africa Neurostimulation Devices Sales and Market Share by Type
5.3 Africa Neurostimulation Devices Sales and Market Share by Application
5.4 Africa Neurostimulation Devices Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Neurostimulation Devices Sales Volume by Countries (2012-2017)
5.4.2 Africa Neurostimulation Devices Revenue by Countries (2012-2017)
5.4.3 South Africa Neurostimulation Devices Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Neurostimulation Devices Sales and Growth Rate (2012-2017)
5.4.5 Egypt Neurostimulation Devices Sales and Growth Rate (2012-2017)
5.4.6 Algeria Neurostimulation Devices Sales and Growth Rate (2012-2017)

6 EMEA Neurostimulation Devices Manufacturers/Players Profiles and Sales Data
6.1 Medtronic
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Neurostimulation Devices Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Medtronic Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Boston Scientific
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Neurostimulation Devices Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Boston Scientific Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 St.Jude Medical
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Neurostimulation Devices Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 St.Jude Medical Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 LivaNova (Cyberonics)
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Neurostimulation Devices Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 LivaNova (Cyberonics) Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Nevro
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Neurostimulation Devices Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Nevro Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Inspire Medical Systems
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Neurostimulation Devices Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Inspire Medical Systems Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 NeuroPace
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Neurostimulation Devices Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 NeuroPace Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Autonomic Technologies
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Neurostimulation Devices Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Autonomic Technologies Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 NeuroSigma
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Neurostimulation Devices Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 NeuroSigma Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Neuros Medical
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Neurostimulation Devices Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Neuros Medical Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 ImThera Medical
6.12 Synapse Biomedical
6.13 Atrotech
6.14 ElectroCore
6.15 SPR Therapeutics
6.16 NeuroMetrix

7 Neurostimulation Devices Manufacturing Cost Analysis
7.1 Neurostimulation Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neurostimulation Devices

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Neurostimulation Devices Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neurostimulation Devices Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Neurostimulation Devices Market Forecast (2017-2022)
11.1 EMEA Neurostimulation Devices Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Neurostimulation Devices Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Neurostimulation Devices Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Neurostimulation Devices Price and Trend Forecast (2017-2022)
11.2 EMEA Neurostimulation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Neurostimulation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Neurostimulation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Neurostimulation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Neurostimulation Devices Sales Forecast by Type (2017-2022)
11.7 EMEA Neurostimulation Devices Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix

To Purchase this premium Report With Complete TOC at http://globalqyresearch.com/checkout-form/0/219467

About Us:

Global QYResearch (http://globalqyresearch.com/) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 32392407

Email: sales@globalqyresearch.com

Follow us:https://www.linkedin.com/company/global-qy-research

Twitter: https://twitter.com/gqyresearch

Comments (0)

Add comment

Comment